Table 3.
Details of toxicity observed in weekly and 3-weekly groups.
Details | Neutropenia | Mucositis | Nausea/vomiting | Diarrhea | Neuropathy | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Weekly | 3-Weekly | Weekly | 3-Weekly | Weekly | 3-Weekly | Weekly | 3-Weekly | Weekly | 3-Weekly | |||||||||||
N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | |
Grade-I and II | 15 | 36.6 | 13 | 31.7 | 26 | 63.4 | 12 | 29.3 | 22 | 53.7 | 11 | 26.8 | 8 | 19.6 | 21 | 51.2 | 8 | 19.5 | 15 | 36.6 |
Grade III | 1 | 2.4 | 5 | 12.2 | 4 | 9.8 | 18 | 43.9 | 3 | 7.3 | 24 | 58.5 | 0 | 0 | 4 | 9.8 | 0 | 0 | 1 | 2.4 |
Grade IV | 2 | 4.9 | 13 | 31.7 | 0 | 0 | 11 | 26.8 | 0 | 0 | 6 | 14.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Nil | 23 | 56.1 | 10 | 24.4 | 11 | 26.8 | 0 | 0 | 16 | 39 | 0 | 0 | 33 | 80.5 | 16 | 39 | 33 | 80.5 | 25 | 61 |
Total | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 | 41 | 100 |